Skip to main content
. Author manuscript; available in PMC: 2013 Mar 16.
Published in final edited form as: Vaccine. 2012 Feb 1;30(13):2309–2314. doi: 10.1016/j.vaccine.2012.01.058

Figure 2.

Figure 2

Antibody levels at baseline and 1 month following final vaccine dose by genotype among 182 FSWs in Lima, Peru.

Horizontal lines represent antibody cutoffs for seropositivity

The box contains 25th to 75th percentile, and the upper bars are 95%

Statistically significant differences between antibody levels at day0/month7 P<.01